Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

ClinicalTrials.gov ID: NCT01714713

Public ClinicalTrials.gov record NCT01714713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 6:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter 26-Week Extension Study to Evaluate the Safety and Clinical Effects of Prolonged Exposure to Two Doses of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist, as an Adjunctive Pro-cognitive Treatment in Subjects With Schizophrenia on Chronic Stable Atypical Antipsychotic Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to further investigate the safety of prolonged exposure to EVP-6124 in subjects with Schizophrenia receiving a stable dose of an atypical antipsychotic who completed double-blind treatment on studies EVP-6124-015 and EVP-6124-016.

Study identification

NCT ID
NCT01714713
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
FORUM Pharmaceuticals Inc
Industry
Enrollment
830 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2013 (Type not available)
Primary completion
Oct 2015 (Actual)
Completion
Oct 2015 (Actual)
Last update posted
May 3, 2016

2013 – 2015

United States locations

U.S. sites
69
U.S. states
24
U.S. cities
69
Facility City State ZIP Site status
Not listed Little Rock Arkansas — —
Not listed Anaheim California — —
Not listed Bellflower California — —
Not listed Cerritos California — —
Not listed Chino California — —
Not listed Costa Mesa California — —
Not listed Culver City California — —
Not listed Downey California — —
Not listed Escondido California — —
Not listed Garden Grove California — —
Not listed Glendale California — —
Not listed Los Angeles California — —
Not listed Mesa California — —
Not listed Norwalk California — —
Not listed Oakland California — —
Not listed Oceanside California — —
Not listed Orange California — —
Not listed Riverside California — —
Not listed San Diego California — —
Not listed San Gabriel California — —
Not listed Santa Ana California — —
Not listed Sherman Oaks California — —
Not listed Torrance California — —
Not listed Washington D.C. District of Columbia — —
Not listed Lauderhill Florida — —
Not listed Miami Florida — —
Not listed Miami Springs Florida — —
Not listed North Miami Florida — —
Not listed Oakland Park Florida — —
Not listed Orange City Florida — —
Not listed Orlando Florida — —
Not listed Atlanta Georgia — —
Not listed Marietta Georgia — —
Not listed Smyrna Georgia — —
Not listed Chicago Illinois — —
Not listed Oak Brook Illinois — —
Not listed Oak Park Illinois — —
Not listed Wichita Kansas — —
Not listed Lake Charles Louisiana — —
Not listed Shreveport Louisiana — —
Not listed Boston Massachusetts — —
Not listed Minneapolis Minnesota — —
Not listed Flowood Mississippi — —
Not listed Creve Coeur Missouri — —
Not listed O'Fallon Missouri — —
Not listed Saint Charles Missouri — —
Not listed St Louis Missouri — —
Not listed Lincoln Nebraska — —
Not listed Omaha Nebraska — —
Not listed Nashua New Hampshire — —
Not listed Princeton New Jersey — —
Not listed Albuquerque New Mexico — —
Not listed Cedarhurst New York — —
Not listed Jamaica New York — —
Not listed New York New York — —
Not listed Charlotte North Carolina — —
Not listed Cleveland Ohio — —
Not listed Shaker Hts. Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Conshohocken Pennsylvania — —
Not listed Jenkintown Pennsylvania — —
Not listed Norristown Pennsylvania — —
Not listed Philadelphia Pennsylvania — —
Not listed Phoenixville Pennsylvania — —
Not listed Austin Texas — —
Not listed Dallas Texas — —
Not listed Salt Lake City Utah — —
Not listed Bellevue Washington — —
Not listed Spokane Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01714713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2016 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01714713 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →